Warning: error_log(/dades/dugi/log//querys.log) [function.error-log]: failed to open stream: Read-only file system in /dades/dugi/lib/log/log.php on line 32
DUGi: Llistar Títols | Vázquez Martín, Alejandro | 0 - 18


Llistar Títols per Autor "Vázquez Martín, Alejandro"

S'han trobat 18 ítems

Llistant ítems des de 0 a 18:

  1   
FormatDataTítolAutor
FormatDataTítolAutor
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2011 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz Duran, Maria Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs abril 2012 Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2008 Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2012 Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
out url icon Recercat Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
out url icon Recercat Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
out url icon Recercat 5 juny 2018 Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2007 An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review) Ferrer Soler, Laura ; Vázquez Martín, Alejandro ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel ; Llorens Duran, Rafael de ; Colomer, Ramon
out url icon Recercat An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review) Ferrer Soler, Laura ; Vázquez Martín, Alejandro ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel ; Llorens Duran, Rafael de ; Colomer, Ramon
  1   

Matèries


Warning: error_log(/dades/dugi/log//dugi.log) [function.error-log]: failed to open stream: Read-only file system in /dades/dugi/lib/log/log.php on line 32

Autors


Warning: error_log(/dades/dugi/log//dugi.log) [function.error-log]: failed to open stream: Read-only file system in /dades/dugi/lib/log/log.php on line 32


Warning: fopen(/dades/dugi/cache/02434224bd44e2c404171868b9fdbb41_.html) [function.fopen]: failed to open stream: Read-only file system in /dades/dugi/end_cache.php on line 2

Warning: Unknown: write failed: No space left on device (28) in Unknown on line 0

Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/var/lib/php5) in Unknown on line 0